Efficacy News and Research

RSS
Research findings pave new ways to treat gastrointestinal disorders

Research findings pave new ways to treat gastrointestinal disorders

Investigational c-Met inhibitor shows early promise in NSCLC

Investigational c-Met inhibitor shows early promise in NSCLC

Researchers find way to replace Paneth cells with two small molecules that maintain stem cells

Researchers find way to replace Paneth cells with two small molecules that maintain stem cells

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Lexicon announces top-line results from initial Phase 2 study of LX1033 for treatment of IBS-d

Lexicon announces top-line results from initial Phase 2 study of LX1033 for treatment of IBS-d

Study supports use of EndoBarrier Therapy for patients with type 2 diabetes and obesity

Study supports use of EndoBarrier Therapy for patients with type 2 diabetes and obesity

Researchers use hyperthermia to treat patients with malignant glioma

Researchers use hyperthermia to treat patients with malignant glioma

IRCM researcher sheds light on inconsistencies between pharmacogenomic studies

IRCM researcher sheds light on inconsistencies between pharmacogenomic studies

Vitamin D2 supplementation is promising treatment for pain, depression in type 2 diabetes

Vitamin D2 supplementation is promising treatment for pain, depression in type 2 diabetes

Four-drug regimen shows first-line efficacy in advanced NSCLC

Four-drug regimen shows first-line efficacy in advanced NSCLC

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Soligenix initiates orBec Phase 2 study for GI manifestations of chronic GVHD

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Osiris: CMS releases proposed ruling for reimbursement of skin substitutes in hospital outpatient setting

Osiris: CMS releases proposed ruling for reimbursement of skin substitutes in hospital outpatient setting

UC San Diego biophysicists discover how antibiotic resistance allows bacteria to multiply

UC San Diego biophysicists discover how antibiotic resistance allows bacteria to multiply

Study reveals new mechanism that may block formation of new blood vessels and cancer growth

Study reveals new mechanism that may block formation of new blood vessels and cancer growth

Health insurance coverage does not increase risky behavior

Health insurance coverage does not increase risky behavior

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Research: Human neural stem cells could improve blood flow in critical limb ischemia

Research: Human neural stem cells could improve blood flow in critical limb ischemia

QRxPharma refiles MOXDUO New Drug Application with US FDA

QRxPharma refiles MOXDUO New Drug Application with US FDA

Researchers successfully target T lymphocytes which play key role in body's immune response

Researchers successfully target T lymphocytes which play key role in body's immune response

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.